1. Methylene Blue in the Treatment of Neuropsychiatric Disorders

   • Martin Alda

   Leading Article 29 May 2019 Pages: 719 - 725

2. Neurological and Psychiatric Adverse Effects of Antimicrobials

   • Madison K. Bangert
   • Rodrigo Hasbun

   Review Article 18 July 2019 Pages: 727 - 753

3. Branched-Chain Amino Acids and Seizures: A Systematic Review of the Literature

   • Shaun E. Gruenbaum
   • Eric C. Chen
   • Tore Eid

   Systematic Review 16 July 2019 Pages: 755 - 770

   

4. Intravenous Brivaracetam in the Treatment of Status Epilepticus: A Systematic Review

   • Francesco Brigo
   • Simona Lattanzi
   • Eugen Trinka

   Systematic Review 24 July 2019 Pages: 771 - 781

   

5. Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets

   • Tina deVries
   • Angela Dentiste
   • David Jacobs

   Original Research Article Open access 24 July 2019 Pages: 783 - 789

   

6. Temporal Trends and Predictors of Drug Utilization and Outcomes in First-Ever Stroke Patients: A Population-Based Study Using the Singapore Stroke Registry

   • See-Hwee Yeo
   • Wai-Ping Yau

   Original Research Article 16 July 2019 Pages: 791 - 815

   

7. Objective Derivation of the Morphology and Staging of Visual Field Loss Associated with Long-Term Vigabatrin Therapy

   • John M. Wild
   • Philip E. M. Smith
   • Carlo Knupp

   Original Research Article 27 June 2019 Pages: 817 - 829

   

8. Immune Globulin Subcutaneous (Human) 20% (Hizentra^®): A Review in Chronic Inflammatory Demyelinating Polyneuropathy

   • Yvette N. Lamb
   • Yahiya Y. Syed
   • Sohita Dhillon

   Adis Drug Evaluation 25 July 2019 Pages: 831 - 838

9. Correction to: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy

   • Zeinab Gharaylou
   • Abbas Tafakhori
   • Mahmoudreza Hadjighassem

   Correction 23 July 2019 Pages: 839 - 839